 |
|
New study proves that pain is not a symptom of arthritis, pain causes arthritis
September 30, 2008New treatments will seek to interrupt 'crosstalk' between joints and the spinal cord
Pain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism. More specifically, the study revealed that pain signals originating in arthritic joints, and the biochemical processing of those signals as they reach the spinal cord, worsen and expand arthritis. In addition, researchers found that nerve pathways carrying pain signals transfer inflammation from arthritic joints to the spine and back again, causing disease at both ends.
Technically, pain is a patient's conscious realization of discomfort. Before that can happen, however, information must be carried along nerve cell pathways from say an injured knee to the pain processing centers in dorsal horns of the spinal cord, a process called nociception. The current study provides strong evidence that two-way, nociceptive "crosstalk" may first enable joint arthritis to transmit inflammation into the spinal cord and brain, and then to spread through the central nervous system (CNS) from one joint to another.
Furthermore, if joint arthritis can cause neuro-inflammation, it could have a role in conditions like Alzheimer's disease, dementia and multiple sclerosis. Armed with the results, researchers have identified likely drug targets that could interfere with key inflammatory receptors on sensory nerve cells as a new way to treat osteoarthritis (OA), which destroys joint cartilage in 21 million Americans. The most common form of arthritis, OA eventually brings deformity and severe pain as patients loose the protective cushion between bones in weight-bearing joints like knees and hips.
"Until relatively recently, osteoarthritis was believed to be due solely to wear and tear, and inevitable part of aging," said Stephanos Kyrkanides, D.D.S., Ph.D., associate professor of Dentistry at the University of Rochester Medical Center. "Recent studies have revealed, however, that specific biochemical changes contribute to the disease, changes that might be reversed by precision-designed drugs. Our study provides the first solid proof that some of those changes are related to pain processing, and suggests the mechanisms behind the effect," said Kyrkanides, whose work on genetics in dentistry led to broader applications. The common ground between arthritis and dentistry: the jaw joint is a common site of arthritic pain.
Study Details
Past studies have shown that specific nerve pathways along which pain signals travel repeatedly become more sensitive to pain signals with each use. This may be a part of ancient survival skill (if that hurt once, don't do it again). Secondly, pain has long been associated with inflammation (swelling and fever).
In fact, past research has shown that the same chemicals that cause inflammation also cause the sensation of pain and hyper-sensitivity to pain if injected. Kyrkanides' work centers around one such pro-inflammatory, signaling chemical called Interleukin 1-beta (IL-1β), which helps to ramp up the bodies attack on an infection.
Specifically, Kyrkanides' team genetically engineered a mouse where they could turn up on command the production of IL-1β in the jaw joint, a common site of arthritis. Experiments showed for the first time that turning up IL-1β in a peripheral joint caused higher levels of IL-1β to be produced in the dorsal horns of the spinal cord as well.
Using a second, even more elaborately engineered mouse model, the team also demonstrated for the first time that creating higher levels of IL-1β in cells called astrocytes in the spinal cord caused more osteoarthritic symptoms in joints. Past studies had shown astrocytes, non-nerve cells (glia) in the central nervous system that provide support for the spinal cord and brain, also serve as the immune cells of CNS organs. Among other things, they release cytokines like IL-1β to fight disease when triggered. The same cytokines released from CNS glia may also be released from neurons in joints, possibly explaining how crosstalk carries pain, inflammation and hyper-sensitivity back and forth.
In both mouse models, experimental techniques that shut down IL-1β signaling reversed the crosstalk effects. Specifically, researchers used a molecule, IL-1RA, known to inhibit the ability of IL-1β to link up with its receptors on nerve cells. Existing drugs (e.g. Kineret® (anakinra), made by Amgen and indicated for rheumatoid arthritis) act like IL-1RA to block the ability IL-1β to send a pain signal through its specific nerve cell receptor, and Kyrkanides' group is exploring a new use for them as osteoarthritis treatment.
The implications of this process go further, however, because the cells surrounding sensory nerve cell pathways too can be affected by crosstalk. If 10 astrocytes secrete IL-1β in response to a pain impulse, Kyrkanides said, perhaps 1,000 adjacent cells will be affected, greatly expanding the field of inflammation. Spinal cord astrocytes are surrounded by sensory nerve cells that connect to other areas of the periphery, further expanding the effect. According to Kyrkanides' model, increased inflammation by in the central nervous system can then send signals back down the nerve pathways to the joints, causing the release of inflammatory factors there.
Among the proposed, inflammatory factors is calcitonin gene related peptide (CGRP). The team observed higher levels calcitonin-gene related peptide (CGRP) production in primary sensory fibers in the same regions where IL-1β levels rose, and the release of IL-1β by sensory neurons may cause the release of CGRP in joints. Past studies in Kyrkanides reveal that CGRP can also cause cartilage-producing cells (chondrocytes) to mature too quickly and die, a hallmark of osteoarthritis.
Joining Kyrkanides in the publication from the University of Rochester School of Medicine and Dentistry were co-authors M. Kerry O'Banion, M.D., Ph.D., Ross Tallents, D.D.S., J. Edward Puzas, Ph.D. and Sabine M. Brouxhon, M.D. Paolo Fiorentino was a student contributor and Jennie Miller was involved as Kyrkanides' technical associate. Maria Piancino, led a collaborative effort at the University of Torino, Italy. This work was supported in part by grants from the National Institutes of Health.
"Our study results confirm that joints can export inflammation in the form of higher IL-1β along sensory nerve pathways to the spinal cord, and that higher IL-1β inflammation in the spinal cord is sufficient in itself to create osteoarthritis in peripheral joints," Kyrkanides said. "We believe this to be a vitally important process contributing to orthopaedic and neurological diseases in which inflammation is a factor."
University of Rochester Medical Center
Furthermore, if joint arthritis can cause neuro-inflammation, it could have a role in conditions like Alzheimer's disease, dementia and multiple sclerosis. Armed with the results, researchers have identified likely drug targets that could interfere with key inflammatory receptors on sensory nerve cells as a new way to treat osteoarthritis (OA), which destroys joint cartilage in 21 million Americans. The most common form of arthritis, OA eventually brings deformity and severe pain as patients loose the protective cushion between bones in weight-bearing joints like knees and hips.
"Until relatively recently, osteoarthritis was believed to be due solely to wear and tear, and inevitable part of aging," said Stephanos Kyrkanides, D.D.S., Ph.D., associate professor of Dentistry at the University of Rochester Medical Center. "Recent studies have revealed, however, that specific biochemical changes contribute to the disease, changes that might be reversed by precision-designed drugs. Our study provides the first solid proof that some of those changes are related to pain processing, and suggests the mechanisms behind the effect," said Kyrkanides, whose work on genetics in dentistry led to broader applications. The common ground between arthritis and dentistry: the jaw joint is a common site of arthritic pain.
Study Details
Past studies have shown that specific nerve pathways along which pain signals travel repeatedly become more sensitive to pain signals with each use. This may be a part of ancient survival skill (if that hurt once, don't do it again). Secondly, pain has long been associated with inflammation (swelling and fever).
In fact, past research has shown that the same chemicals that cause inflammation also cause the sensation of pain and hyper-sensitivity to pain if injected. Kyrkanides' work centers around one such pro-inflammatory, signaling chemical called Interleukin 1-beta (IL-1β), which helps to ramp up the bodies attack on an infection.
Specifically, Kyrkanides' team genetically engineered a mouse where they could turn up on command the production of IL-1β in the jaw joint, a common site of arthritis. Experiments showed for the first time that turning up IL-1β in a peripheral joint caused higher levels of IL-1β to be produced in the dorsal horns of the spinal cord as well.
Using a second, even more elaborately engineered mouse model, the team also demonstrated for the first time that creating higher levels of IL-1β in cells called astrocytes in the spinal cord caused more osteoarthritic symptoms in joints. Past studies had shown astrocytes, non-nerve cells (glia) in the central nervous system that provide support for the spinal cord and brain, also serve as the immune cells of CNS organs. Among other things, they release cytokines like IL-1β to fight disease when triggered. The same cytokines released from CNS glia may also be released from neurons in joints, possibly explaining how crosstalk carries pain, inflammation and hyper-sensitivity back and forth.
In both mouse models, experimental techniques that shut down IL-1β signaling reversed the crosstalk effects. Specifically, researchers used a molecule, IL-1RA, known to inhibit the ability of IL-1β to link up with its receptors on nerve cells. Existing drugs (e.g. Kineret® (anakinra), made by Amgen and indicated for rheumatoid arthritis) act like IL-1RA to block the ability IL-1β to send a pain signal through its specific nerve cell receptor, and Kyrkanides' group is exploring a new use for them as osteoarthritis treatment.
The implications of this process go further, however, because the cells surrounding sensory nerve cell pathways too can be affected by crosstalk. If 10 astrocytes secrete IL-1β in response to a pain impulse, Kyrkanides said, perhaps 1,000 adjacent cells will be affected, greatly expanding the field of inflammation. Spinal cord astrocytes are surrounded by sensory nerve cells that connect to other areas of the periphery, further expanding the effect. According to Kyrkanides' model, increased inflammation by in the central nervous system can then send signals back down the nerve pathways to the joints, causing the release of inflammatory factors there.
Among the proposed, inflammatory factors is calcitonin gene related peptide (CGRP). The team observed higher levels calcitonin-gene related peptide (CGRP) production in primary sensory fibers in the same regions where IL-1β levels rose, and the release of IL-1β by sensory neurons may cause the release of CGRP in joints. Past studies in Kyrkanides reveal that CGRP can also cause cartilage-producing cells (chondrocytes) to mature too quickly and die, a hallmark of osteoarthritis.
Joining Kyrkanides in the publication from the University of Rochester School of Medicine and Dentistry were co-authors M. Kerry O'Banion, M.D., Ph.D., Ross Tallents, D.D.S., J. Edward Puzas, Ph.D. and Sabine M. Brouxhon, M.D. Paolo Fiorentino was a student contributor and Jennie Miller was involved as Kyrkanides' technical associate. Maria Piancino, led a collaborative effort at the University of Torino, Italy. This work was supported in part by grants from the National Institutes of Health.
"Our study results confirm that joints can export inflammation in the form of higher IL-1β along sensory nerve pathways to the spinal cord, and that higher IL-1β inflammation in the spinal cord is sufficient in itself to create osteoarthritis in peripheral joints," Kyrkanides said. "We believe this to be a vitally important process contributing to orthopaedic and neurological diseases in which inflammation is a factor."
University of Rochester Medical Center
Osteoarthritis Current Events and Osteoarthritis News RSSStudy finds link between childhood physical abuse and arthritis
Adults who had experienced physical abuse as children have 56 per cent higher odds of osteoarthritis compared to those who have not been abused, according to a new study by University of Toronto researchers.
Trial raises doubts over alternative pain therapy for arthritis
Copper bracelets and magnetic wrist straps are ineffective in relieving arthritis pain, according to a new study led by a University of York academic.
Scientists find obesity alone does not cause arthritis in animals
The link between obesity and osteoarthritis may be more than just the wear and tear on the skeleton caused by added weight.
Hormone promises to keep joint injuries from causing long-term osteoarthritis
An existing osteoporosis drug is the first ever found to prevent cartilage loss from osteoarthritis following injury to a joint, and may also regenerate some cartilage that has been lost to osteoarthritis.
Getting better visualization of joint cartilage through cationic CT contrast agents
In its quest to find new strategies to treat osteoarthritis and other diseases, a Boston University-led research team has reported finding a new computer tomography contrast agent for visualizing the special distributions of glycosaminoglycans (GAGs) - the anionic sugars that account for the strength of joint cartilage.
Cognitive behavioral therapy improves sleep and pain in people with osteoarthritis
A study in the Aug. 15 issue of the Journal of Clinical Sleep Medicine shows that the use of cognitive behavioral therapy for insomnia (CBT-I) is an effective treatment for older patients with osteoarthritis and comorbid insomnia.
New 'biofactories' produce rare healing substances in the endangered Devil's claw plant
Deep in Africa's Kalahari Desert lies the "Devil's claw," a plant that may hold the key to effective treatments for arthritis, tendonitis and other illnesses that affect millions each year.
The disease markers that will aid arthritis research
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression.
Study to assess hip exercises as treatment for osteoarthritis in the knee joints
Researchers at Rush University Medical Center are testing a novel regimen of hip-muscle exercises to decrease the load on the knee joints in patients with osteoarthritis.
Obesity contributes to rapid cartilage loss
Obesity, among other factors, is strongly associated with an increased risk of rapid cartilage loss, according to a study published in the August issue of Radiology.
More Osteoarthritis Current Events and Osteoarthritis News Articles
 |
Osteoarthritis: Preventing and Healing Without Drugs by Peter Bales (Author) Osteoarthritis affects over 20 million Americans and is the most common degenerative disorder in the United States. It causes more disability than any other degenerative disease and is occurring in epidemic proportions throughout the world. In this novel approach to understanding and treating osteoarthritis, orthopaedic surgeon Peter Bales highlights the nutritional connection to this painful and debilitating condition, Dr Bales focuses on new genetic research, which shows that the same poor nutrition responsible for causing increased inflammation in our bodies, along with epidemic rates of obesity, diabetes, and heart disease, is also fuelling the development of osteoarthritis. Among the topics discussed are the following: the mechanisms by which our joints become destroyed. The culprits... |
 |
The Arthritis Handbook: Improve Your Health and Manage the Pain of Osteoarthritis (A DiaMedica Guide to Optimum Wellness) by M.D. Grant Cooper (Author) According to conventional wisdom, arthritis pain is an inevitable part of aging. Not so, says Dr. Grant Cooper in this practical, accessible guide. For those who do develop osteoarthritic conditions, this book offers a blend of commonsense advice, dietary info, targeted exercise, and tips on useful supplements. According to the author, sufferers can often entirely avoid the use of medication, injection therapy, and surgery — approaches that, when necessary, can be used as an opportunity to return to exercise and nutrition to slow the disease’s progress. The book features easy, illustrated exercises, including aerobics and strength training, that can be done at home, at a gym, or under a trainer’s or physical therapist’s supervision. Nutritional and supplement strategies —... |
 |
The Arthritis Cure, Revised and Updated: The Medical Miracle That Can Halt, Reverse, And May Even Cure Osteoarthritis by Jason Theodosakis (Author), Sheila Buff (Author), Barry Fox (Author) Since its original publication in 1996, The Arthritis Cure has swept the nation, providing amazing relief for the millions who suffer chronic arthritis pain. By outlining a nine-point program that includes a new effective supplement, ASU, The Arthritis Cure Revised Edition describes a program that can halt, reverse, and possibly even cure degenerative osteoarthritis. Based on the most recent and cutting-edge medical research, this invaluable resource promises readers: --The latest research indicating that prescription arthritis drugs are not only expensive but can also be dangerous--they can raise blood pressure and damage the kidneys. --New studies supporting the use of glucosamine and chondroitin to treat arthritic symptoms. --Dr. Theodosaki's ratings of the current... |
 |
The Arthritis Foundation's Guide to Good Living with Osteoarthritis, 2nd Edition by Dorothy Foltz-Gray (Author) The Arthritis Foundation's Guide to Good Living With Osteoarthritis provides clear, understandable information on drugs, surgery, do-it-yourself treatments, exercise, alternative therapies and more to beat the pain of osteoarthritis. |
 |
Osteoarthritis: Diagnosis and Medical/Surgical Management by Roland W Moskowitz (Editor), Roy D Altman (Editor), Joseph A Buckwalter (Editor), Victor M Goldberg (Editor), Marc C Hochberg (Editor) Written by the foremost experts, this text is a comprehensive clinical reference on osteoarthritis. Chapters review current information on the epidemiology, etiopathogenesis, and pathology of osteoarthritis, the biochemistry and molecular and cell biology of articular cartilage, and experimental models of osteoarthritis. Major sections focus on clinical presentations, roentgenologic and laboratory diagnosis, and treatment, including pharmacologic treatment, intra-articular therapy, surgery, arthroscopy, and complementary and alternative medicine. The authors discuss the indications, outcomes, and complications of various orthopaedic procedures. Chapters present orthopaedic approaches to osteoarthritis of various joints--the shoulder, hand, wrist, elbow, hip, knee, foot, ankle, and... |
 |
Cosamin DS Joint Health Supplement, Capsules, 210-Count Bottle by Cosamin DS Glucosamine (FCHG49), Chondroitin Sulfate (TRH122). Exclusive formula. Protect your cartilage with the only brand proven to reduce joint pain. (These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.) Easy to swallow. Exclusive trademarked ingredients. The Orthopedic Surgeon and Rheumatologist No. 1 recommended brand. Safe and Economical: There are no known interactions or serious side effects with CosaminDS. Exclusive ingredients allows reduction in the number of capsules taken over time. CosaminDS is Recommended by Doctors and Pharmacists for Joint Health: The only brand proven effective in controlled, published US studies to reduce joint pain. Shown in laboratory tests to protect... |
 |
Stop Osteoarthritis Now: Halting the Baby Boomers' Disease by Harris H. Mcilwain (Author), Debra Fulgham Bruce (Author) What exactly is this debilitating disease? It is an inflammation in or around the joints caused by wear and tear on the cartilage and bone, resulting in pain, swelling, or stiffness in the back, knees, hips, hands, or other joints. The good news is that osteoarthritis can be successfully treated and may even be delayed or prevented. In Stop Osteoarthritis Now! Dr. Harris H. McIlwain provides the reader with a five-step basic treatment plan for self-help involving moist heat, exercise, weight control, medication, and joint protection; a three-step prevention program; a guide to nonstandard treatments, such as vitamin supplements, creams, spas, meditation, acupuncture, and more; and stress-reduction tools that can help end osteoarthritis pain, including relaxation techniques, visualization,... |
 |
Osteoarthritis (The Facts) by Nigel K Arden (Author), Elizabeth Arden (Author), David Hunter (Author) Osteoarthritis is a common disorder of the joints that affects more than 2 million people in the UK, and studies suggest that this number will double in the next 20 years. The condition is strongly associated with ageing and is believed to affect up to 30% of people over 60 years of age. There are a number of misconceptions surrounding osteoarthritis and this, combined with the lack of effective drug treatments, often leaves patients dispirited and confused about their condition. Osteoarthritis: The Facts helps patients and their carers better understand their condition with a view towards self-management. The text is designed to be easy to read and is organized into two main parts. Part 1 details what osteoarthritis is, what causes it, who it affects, what the main symptoms are,... |
 |
All About Osteoarthritis: The Definitive Resource for Arthritis Patients and Their Families by Nancy E. Lane (Author), Daniel J. Wallace (Author) Osteoarthritis afflicts about 25 million people in the United States--two-thirds of all people over 65--and the numbers will only grow in the coming years as baby boomers age. Yet few who suffer from this disease know much about it--how to relieve the pain, what exercises might help lessen their suffering, how to cut down on visits to the doctor. In All About Osteoarthritis, two leading authorities on the disease--Nancy E. Lane and Daniel J. Wallace--join forces to provide the most up-to-date and comprehensive discussion of osteoarthritis available, explaining what osteoarthritis is, how patients can help themselves, and how to find the best resources to manage the disorder. The authors offer information in a clear and accessible style, with detailed illustrations showing how key... |
 |
Water Exercises for Osteoarthritis: The Effective Way to Reduce Pain and Stiffness, While Increasing Endurance and Strength by Ann A. Rosenstein (Author) Water Exercises for Osteoarthritis contains over 100 individual exercises and examples of exercise routines. It is richly illustrated with over 500 pictures so the reader can see all of the elements that go into an exercise program: equipment, warm-ups, stretching, aerobic exercises, strength exercises, balance exercises, exercises focusing on the abdominals, neck exercises, and cool downs. Included, also, is information on medications, vitamins and minerals, herbs, diet, and nutrition. Osteoarthritis is the most common form of arthritis, affecting over 21 million people in the United States. As Americans age, the number of people affected is expected to increase to 40 million by 2020. The pain of osteoarthritis causes people to stop exercising and leaves them vulnerable to... |
| © 2009 BrightSurf.com |